W Michael Bonney

Affiliations

  • Director at Bristol Myers Squibb Co (BMY), 2021-06-14
  • Director at Magenta Therapeutics Inc. (MGTA), 2021-06-03
  • Director at Alnylam Pharmaceuticals Inc. (ALNY), 2020-07-06
  • Director at Kaleido Biosciences Inc. (KLDO), 2020-07-01
  • Director at Sarepta Therapeutics Inc. (SRPT), 2020-02-29
  • at Celgene Corp (CELG), 2019-11-22
  • Director at Syros Pharmaceuticals Inc. (SYRS), 2019-06-12
  • Director at Global Blood Therapeutics Inc. (GBT), 2016-06-18
  • Director at Tekla World Healthcare Fund (THW), 2015-08-18
  • Director at Nps Pharmaceuticals Inc (NPSP), 2015-02-25
  • Chief Executive Officer at Cubist Pharmaceuticals Inc (CBST), 2015-01-21
  • Director at Tekla Healthcare Opportunities Fund (THQ), 2014-07-29
  • Director at H&q Life Sciences Investors (HQL), 2014-06-30
  • Director at H&q Healthcare Investors (HQH), 2014-06-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BMY $58.90 88 Director 7,189 2019-12-04 Filing
SRPT $86.74 2,000 Director 7,051 2019-09-09 Filing
KLDO $14.65 2,555 Officer, Director 1,008,523 2019-02-28 Filing
KLDO $13.95 68,965 Officer, Director 1,005,968 2019-02-28 Filing
ALNY $58.36 2,000 Director 4,000 2016-03-09 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CBST $67.50 3,036 Officer, Director 175,859 2014-05-15 Filing
CBST $69.00 3,840 Officer, Director 172,645 2014-05-14 Filing
CBST $81.25 100,000 Officer, Director 168,485 2014-02-27 Filing
CBST $75.60 3,112 Officer, Director 168,485 2014-02-20 Filing
CBST $50.00 60,000 Officer, Director 161,518 2013-05-20 Filing